Advertisement

Complications of Regional Anesthesia in Chronic Pain Therapy

  • Philip W. H. Peng
  • Vincent W. S. Chan

Abstract

Interest in interventional pain management is on the rise, as indicated by an increased enrollment into the anesthesiology pain fellowship programs in North America.1 The prevalence of treatment-related complications has also increased, as suggested in a recent Closed Claims study.2 In this chapter, we discuss sympathetic, visceral, and somatic blocks frequently used in the management of chronic pain. To understand how complications arise, it is necessary to review the anatomy and techniques of the blocks, which can be used for diagnostic or therapeutic purposes. It is also important to understand some of the unique drugs used in this setting (e.g., neurolytic agents and corticosteroids). In general, procedure-related damage can result from needle insertion, misplacement or unanticipated spread of the drug, drug toxicity, injection of the wrong substance, or from an idiosyncratic reaction. Postblock physiologic changes may also add to complications.

Keywords

Cancer Pain Complex Regional Pain Syndrome Spinal Cord Stimulation Epidural Morphine Epidural Injection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lema M. What’s the name of the game? ASA Newslett 2002;66:1.Google Scholar
  2. 2.
    Fitzgibbon DR, Posner KL, Domino KB, Caplan RA, Lee LA, Cheney FW. Chronic pain management: American Society of Anesthesiologists Closed Claims Project. Anesthesiology 2004;100:98–105.PubMedGoogle Scholar
  3. 3.
    Breivik H. Sympathetic blocks. In: Breivik H, Campbell W, Eccleston C, eds. Clinical Pain Management: Practical Applications and Procedures. 1st ed. London: Arnold; 2003:233–246.Google Scholar
  4. 4.
    Hogan QH, Abram SE. Diagnostic and prognostic neural blockade. In: Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. 3rd ed. Philadelphia: Lippincott-Raven; 1998:837–878.Google Scholar
  5. 5.
    Raj PR. Stellate ganglion block. In: Waldman SD, Winnie AP, eds. Interventional Pain Management. 1st ed. Philadelphia: WB Saunders; 1996:267–274.Google Scholar
  6. 6.
    Moore DC. Puncture of organs and blood vessels. In: Complications of Regional Anaesthesia. Springfield, IL: Charles C. Thomas; 1955.Google Scholar
  7. 7.
    Kozody R, Ready LB, Barsa JE, Murphy TM. Dose requirement of local anaesthetic to produce grand mal seizure during stellate ganglion block. Can Anaesth Soc J 1982;29: 489–491.PubMedGoogle Scholar
  8. 8.
    Ellis JS Jr, Ramamurthy S. Seizure following stellate ganglion block after negative aspiration and test dose. Anesthesiology 1986;64:533–534.PubMedGoogle Scholar
  9. 9.
    Adelman MH. Cerebral air embolism complicating stellate ganglion block. J Mt Sinai Hosp 1948;15:28.Google Scholar
  10. 10.
    Stannard CF, Glynn CJ, Smith SP. Dural puncture during attempted stellate ganglion block. Anaesthesia 1990;45:952–954.PubMedGoogle Scholar
  11. 11.
    Bruyns T, Devulder J, Vermeulen H, De Colvenaer L, Roily G. Possible inadvertent subdural block following attempted stellate ganglion blockade. Anaesthesia 1991;46: 747–749.PubMedGoogle Scholar
  12. 12.
    Wulf H, Maier C. Complications and side effects of stellate ganglion blockade. Results of a questionnaire survey [German]. Anaesthesist 1992;41:146–151.PubMedGoogle Scholar
  13. 13.
    Allen G, Samson B. Contralateral Horner’s syndrome following stellate ganglion block. Can Anaesth Soc J 1986;33:112–113.PubMedGoogle Scholar
  14. 14.
    Tochinai H, Wakusawa R, Segawa Y, Iwabuchi T, Goto T. Case of severe arrhythmia after stellate ganglion block [Japanese]. Masui 1974;23:548–552.PubMedGoogle Scholar
  15. 15.
    Schlack W, Schafer S, Thamer V. Left stellate ganglion block impairs left ventricular function. Anesth Analg 1994;79:1082–1088.PubMedGoogle Scholar
  16. 16.
    Lehmann LJ, Warfield CA, Bajwa ZH. Migraine headache following stellate ganglion block for reflex sympathetic dystrophy. Headache 1996;36:335–337.PubMedGoogle Scholar
  17. 17.
    Romanoff ME, Ellis JS Jr. Bupivacaine toxicity after stellate ganglion block. Anesth Analg 1991;73:505–506.PubMedGoogle Scholar
  18. 18.
    Rocco AG, Palombi D, Raeke D. Anatomy of the lumbar sympathetic chain. Reg Anesth 1995;20:13–19.PubMedGoogle Scholar
  19. 19.
    Peng PW, Castano ED. Survey of chronic pain practice by anesthesiologists in Canada. Can J Anaesth 2005;52:383–389.PubMedGoogle Scholar
  20. 20.
    Artusio JD, Stevens RA, Lineberry PJ. Postdural puncture headache after lumbar sympathetic block: a report of two cases. Reg Anesth 1991;16:288.Google Scholar
  21. 21.
    Waldman SD. Horner’s syndrome resulting from a lumbar sympathetic block. Anesthesiology 1989;70:882.PubMedGoogle Scholar
  22. 22.
    Cherry DA, Rao DM. Lumbar sympathetic and coeliac plexus blocks. An anatomical study in cadavers. Br J Anaesth 1982;54:1037–1039.PubMedGoogle Scholar
  23. 23.
    Furlan AD, Lui PW, Mailis A. Chemical sympathectomy for neuropathic pain: does it work? Case report and systematic literature review. Clin J Pain 2001;17:327–336.PubMedGoogle Scholar
  24. 24.
    Reid W, Watt JK, Gray TG. Phenol injection of the sympathetic chain. Br J Surg 1970;57:45–50.PubMedGoogle Scholar
  25. 25.
    Antao B, Rowlands TE, Singh NP, McCleary AJ. Pelviureteric junction disruption as a complication of chemical lumbar sympathectomy. Cardiovasc Surg 2003;11:42–44.PubMedGoogle Scholar
  26. 26.
    Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997;73:123–139.PubMedGoogle Scholar
  27. 27.
    Kalmanovitch DV, Hardwick PB. Hypotension after guanethidine block. Anaesthesia 1988;43:256.PubMedGoogle Scholar
  28. 28.
    Sharpe E, Milaszkiewicz R, Carli F. A case of prolonged hypotension following intravenous guanethidine block. Anaesthesia 1987;42:1081–1084.PubMedGoogle Scholar
  29. 29.
    Woo R, McQueen J. Apnea and syncope following intravenous guanethidine Bier block in the same patient on two different occasions. Anesthesiology 1987;67:281–282.PubMedGoogle Scholar
  30. 30.
    Singler RC. An improved technique for alcohol neurolysis of the celiac plexus. Anesthesiology 1982;56:137–141.PubMedGoogle Scholar
  31. 31.
    Ischia S, Luzzani A, Ischia A, Faggion S. A new approach to the neurolytic block of the coeliac plexus: the transaortic technique. Pain 1983;16:333–341.PubMedGoogle Scholar
  32. 32.
    Montero MA, Vidal LF, Aguilar Sanchez JL, Donoso BL. Percutaneous anterior approach to the coeliac plexus using ultrasound. Br J Anaesth 1989;62:637–640.Google Scholar
  33. 33.
    Klapman JB, Chang KJ. Endoscopic ultrasound-guided fine-needle injection. Gastrointest Endosc Clin North Am 2005;15:169–177.Google Scholar
  34. 34.
    Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995;80:290–295.PubMedGoogle Scholar
  35. 35.
    Chan VW. Chronic diarrhea: an uncommon side effect of celiac plexus block. Anesth Analg 1996;82:205–207.PubMedGoogle Scholar
  36. 36.
    Takahashi M, Yoshida A, Ohara T, et al. Silent gastric perforation in a pancreatic cancer patient treated with neurolytic celiac plexus block. J Anesth 2003;17:196–198.PubMedGoogle Scholar
  37. 37.
    Sett SS, Taylor DC. Aortic pseudoaneurysm secondary to celiac plexus block. Ann Vase Surg 1991;5:88–91.Google Scholar
  38. 38.
    Kaplan R, Schiff-Keren B, Alt E. Aortic dissection as a complication of celiac plexus block. Anesthesiology 1995;83:632–635.PubMedGoogle Scholar
  39. 39.
    Wilson PR. Incidental discography during celiac plexus block. Anesthesiology 1992; 76:314–316.PubMedGoogle Scholar
  40. 40.
    Fine PG, Bubela C. Chylothorax following celiac plexus block. Anesthesiology 1985;63: 454–456.PubMedGoogle Scholar
  41. 41.
    Pateman J, Williams MP, Filshie J. Retroperitoneal fibrosis after multiple coeliac plexus blocks. Anaesthesia 1990;45:309–310.PubMedGoogle Scholar
  42. 42.
    Navarro-Martinez J, Montes A, Comps O, Sitges-Serra A. Retroperitoneal abscess after neurolytic celiac plexus block from the anterior approach. Reg Anesth Pain Med 2003;28:528–530.PubMedGoogle Scholar
  43. 43.
    Gress F, Schmitt C, Sherman J, Ciaccia D, Ikenberry J, Lehman G. Endoscopic ultra-sound-guided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience. Am J Gastroenterol 2001;96:409–416.PubMedGoogle Scholar
  44. 44.
    De Conno F, Caraceni A, Aldrighetti L, et al. Paraplegia following coeliac plexus block. Pain 1993;55:383–385.PubMedGoogle Scholar
  45. 45.
    Brown DL, Rorie DK. Altered reactivity of isolated segmental lumbar arteries of dogs following exposure to ethanol and phenol. Pain 1994;56:139–143.PubMedGoogle Scholar
  46. 46.
    Galizia EJ, Lahiri SK. Paraplegia following coeliac plexus block with phenol. Case report. Br J Anaesth 1974;46:539–540.Google Scholar
  47. 47.
    Cherry DA, Lamberty J. Paraplegia following coeliac plexus block. Anaesth Intensive Care 1984;12:59–61.PubMedGoogle Scholar
  48. 48.
    Takeda J, Namai H, Fukushima K. Anterior spinal artery syndrome after left celiac plexus block. Anesth Analg 1996;83:178–179.PubMedGoogle Scholar
  49. 49.
    Wong GY, Brown DL. Transient paraplegia following alcohol celiac plexus block. Reg Anesth 1995;20:352–355.PubMedGoogle Scholar
  50. 50.
    Davies DD. Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med 1993;86:264–266.PubMedGoogle Scholar
  51. 51.
    Fugere F, Lewis G. Coeliac plexus block for chronic pain syndromes. Can J Anaesth 1993;40:954–963.PubMedGoogle Scholar
  52. 52.
    Fitzgibbon DR, Schmiedl UP, Sinanan MN. Computed tomography-guided neurolytic celiac plexus block with alcohol complicated by superior mesenteric venous thrombosis. Pain 2001;92:307–310.PubMedGoogle Scholar
  53. 53.
    Gaudy JH, Tricot C, Sezeur A. Serious heart rate disorders following perioperative splanchnic nerve phenol nerve block [French]. Can J Anaesth 1993;40:357–359.PubMedGoogle Scholar
  54. 54.
    Jain J, Hirsch R, Shah N, Bedford R. Blood levels of ethanol following celiac plexus block. Anesth Analg 1989;68(suppl):S135.Google Scholar
  55. 55.
    Noda J, Umeda J, Mori K, Fukunaga T, Mizoi Y. Acetaldehyde syndrome after celiac plexus alcohol block. Anesth Analg 1986;65:1300–1302.PubMedGoogle Scholar
  56. 56.
    Plancarte R, Amescua C, Patt RB, Aldrete JA. Superior hypogastric plexus block for pelvic cancer pain. Anesthesiology 1990;73:236–239.PubMedGoogle Scholar
  57. 57.
    Frymoyer JW. Back pain and sciatica. N Engl J Med 1988;318:291–300.PubMedGoogle Scholar
  58. 58.
    Dreyfuss PH, Dreyer SJ. Lumbar zygapophysial (facet) joint injections. Spine J 2003;3:50S–59S.PubMedGoogle Scholar
  59. 59.
    Dreyfuss P, Schwarzer AC, Lau P, Bogduk N. Specificity of lumbar medial branch and L5 dorsal ramus blocks. A computed tomography study. Spine 1997;22:895–902.PubMedGoogle Scholar
  60. 60.
    Marks RC, Houston T, Thulbourne T. Facet joint injection and facet nerve block: a randomised comparison in 86 patients with chronic low back pain. Pain 1992;49:325–328.PubMedGoogle Scholar
  61. 61.
    Marks R, Semple AJ. Spinal anaesthesia after facet joint injection. Anaesthesia 1988;43:65–66.PubMedGoogle Scholar
  62. 62.
    Thomson SJ, Lomax DM, Collett BJ. Chemical meningism after lumbar facet joint block with local anaesthetic and steroids. Anaesthesia 1991;46:563–564.PubMedGoogle Scholar
  63. 63.
    Cook NJ, Hanrahan P, Song S. Paraspinal abscess following facet joint injection. Clin Rheumatol 1999;18:52–53.PubMedGoogle Scholar
  64. 64.
    Orpen NM, Birch NC. Delayed presentation of septic arthritis of a lumbar facet joint after diagnostic facet joint injection. J Spinal Disord Tech 2003;16:285–287.PubMedGoogle Scholar
  65. 65.
    Lord SM, Bogduk N. Radiofrequency procedures in chronic pain. Best Pract Res Clin Anaesthesiol 2002;16:597–617.PubMedGoogle Scholar
  66. 66.
    Cluff R, Mehio AK, Cohen SP, Chang Y, Sang CN, Stojanovic MP. The technical aspects of epidural steroid injections: a national survey. Anesth Analg 2002;95:403–408.PubMedGoogle Scholar
  67. 67.
    Abram SE. Treatment of lumbosacral radiculopathy with epidural steroids. Anesthesiology 1999;91:1937–1941.PubMedGoogle Scholar
  68. 68.
    Waldman SD. Cervical epidural nerve block. In: Waldman SD, Winnie AP, eds. Interventional Pain Management. Philadelphia: WB Saunders; 1996:275.Google Scholar
  69. 69.
    Gajraj NM. Selective nerve root blocks for low back pain and radiculopathy. Reg Anesth Pain Med 2004;29:243–256.PubMedGoogle Scholar
  70. 70.
    Rathmell JP, Aprill C, Bogduk N. Cervical transforaminal injection of steroids. Anesthesiology 2004;100:1595–1600.PubMedGoogle Scholar
  71. 71.
    Stojanovic MP, Vu TN, Caneris O, Slezak J, Cohen SP, Sang CN. The role of fluoroscopy in cervical epidural steroid injections: an analysis of contrast dispersal patterns. Spine 2002;27:509–514.PubMedGoogle Scholar
  72. 72.
    Peng PW, Smedstad KG. Litigation in Canada against anesthesiologists practicing regional anesthesia. A review of closed claims. Can J Anaesth 2000;47:105–112.PubMedGoogle Scholar
  73. 73.
    Abram SE, O’Connor TC. Complications associated with epidural steroid injections. Reg Anesth 1996;21:149–162.PubMedGoogle Scholar
  74. 74.
    Benzon HT, Gissen AJ, Strichartz GR, Avram MJ, Covino BG. The effect of polyethylene glycol on mammalian nerve impulses. Anesth Analg 1987;66:553–559.PubMedGoogle Scholar
  75. 75.
    Knight JW, Cordingley JJ, Palazzo MG. Epidural abscess following epidural steroid and local anaesthetic injection. Anaesthesia 1997;52:576–578.PubMedGoogle Scholar
  76. 76.
    Huang RC, Shapiro GS, Lim M, Sandhu HS, Lutz GE, Herzog RJ. Cervical epidural abscess after epidural steroid injection. Spine 2004;29:E7–E9.PubMedGoogle Scholar
  77. 77.
    Saigal G, Donovan Post MJ, Kozic D. Thoracic intradural Aspergillus abscess formation following epidural steroid injection. AJNR Am J Neuroradiol 2004;25:642–644.PubMedGoogle Scholar
  78. 78.
    Dougherty JH Jr, Fraser RA. Complications following intraspinal injections of steroids. Report of two cases. J Neurosurg 1978;48:1023–1025.PubMedGoogle Scholar
  79. 79.
    Cooper AB, Sharpe MD. Bacterial meningitis and cauda equina syndrome after epidural steroid injections. Can J Anaesth 1996;43:471–474.PubMedGoogle Scholar
  80. 80.
    Stambough JL, Booth RE Jr, Rothman RH. Transient hypercorticism after epidural steroid injection. A case report. J.Bone Joint Surg Am 1984;66:1115–1116.PubMedGoogle Scholar
  81. 81.
    Tuel SM, Meythaler JM, Cross LL. Cushing’s syndrome from epidural methylprednisolone. Pain 1990;40:81–84.PubMedGoogle Scholar
  82. 82.
    Knight CL, Burnell JC. Systemic side-effects of extradural steroids. Anaesthesia 1980;35:593–594.PubMedGoogle Scholar
  83. 83.
    Boonen J, Van Distel G, Westhovens R, Dequeker J. Steroid myopathy induced by epidural triamcinolone injection. Br J Rheumatol 1995;34:385–386.PubMedGoogle Scholar
  84. 84.
    Maillefert JF, Aho J, Huguenin MC, et al. Systemic effects of epidural dexamethasone injections. Rev Rhum Engl Ed 1995;62:429–432.PubMedGoogle Scholar
  85. 85.
    Kay J, Findling JW, Raff H. Epidural triamcinolone suppresses the pituitary-adrenal axis in human subjects. Anesth Analg 1994;79:501–505.PubMedGoogle Scholar
  86. 86.
    Jacobs J, Pullan PT, Potter JM, Shenfield GM. Adrenal suppression following extradural steroids. Anaesthesia 1983;38:953–956.PubMedGoogle Scholar
  87. 87.
    Gorski DW, Rao TL, Glisson SN, Chinthagada M, El-Etr AA. Epidural triamcinolone and adrenal response to hypoglycemic stress in dogs. Anesthesiology 1982;57:364–366.PubMedGoogle Scholar
  88. 88.
    Cohn ML, Huntington CT, Byrd SE, Machado AF, Cohn M. Epidural morphine and methylprednisolone. New therapy for recurrent low-back pain. Spine 1986;11:960–963.PubMedGoogle Scholar
  89. 89.
    Dallas TL, Lin RL, Wu WH, Wolskee P. Epidural morphine and methylprednisolone for low-back pain. Anesthesiology 1987;67:408–411.PubMedGoogle Scholar
  90. 90.
    Brechner VL. Epidural morphine and methylprednisolone: new therapy for recurrent low-back pain. Spine 1987;12:827.PubMedGoogle Scholar
  91. 91.
    Rocco AG, Frank E, Kaul AF, Lipson SJ, Gallo JP. Epidural steroids, epidural morphine and epidural steroids combined with morphine in the treatment of post-laminectomy syndrome. Pain 1989;36:297–303.PubMedGoogle Scholar
  92. 92.
    Glynn C, Dawson D, Sanders R. A double-blind comparison between epidural morphine and epidural Clonidine in patients with chronic non-cancer pain. Pain 1988;34:123–128.PubMedGoogle Scholar
  93. 93.
    Botwin KP, Gruber RD, Bouchlas CG, Torres-Ramos FM, Freeman TL, Slaten WK. Complications of fluoroscopically guided transforaminal lumbar epidural injections. Arch Phys Med Rehabil 2000;81:1045–1050.PubMedGoogle Scholar
  94. 94.
    Furman MB, O’Brien EM, Zgleszewski TM. Incidence of intravascular penetration in transforaminal lumbosacral epidural steroid injections. Spine 2000;25:2628–2632.PubMedGoogle Scholar
  95. 95.
    Rathmell JP, Benzon HT. Transforaminal injection of steroids: should we continue? Reg Anesth Pain Med 2004;29:397–399.PubMedGoogle Scholar
  96. 96.
    Brouwers PJ, Kottink EJ, Simon MA, Prevo RL. A cervical anterior spinal artery syndrome after diagnostic blockade of the right C6-nerve root. Pain 2001;91:397–399.PubMedGoogle Scholar
  97. 97.
    Tiso RL, Cutler T, Catania JA, Whalen K. Adverse central nervous system sequelae after selective transforaminal block: the role of corticosteroids. Spine J 2004;4:468–474.PubMedGoogle Scholar
  98. 98.
    McMillan MR, Crumpton C. Cortical blindness and neurologic injury complicating cervical transforaminal injection for cervical radiculopathy. Anesthesiology 2003;99:509–511.PubMedGoogle Scholar
  99. 99.
    Houten JK, Errico TJ. Paraplegia after lumbosacral nerve root block: report of three cases. Spine J 2002;2:70–75.PubMedGoogle Scholar
  100. 100.
    Huntoon MA, Martin DP. Paralysis after transforaminal epidural injection and previous spinal surgery. Reg Anesth Pain Med 2004;29:494–495.PubMedGoogle Scholar
  101. 101.
    Baker R, Dreyfuss P, Mercer J, Bogduk N. Cervical transforaminal injection of cortico-steroids into a radicular artery: a possible mechanism for spinal cord injury. Pain 2003;103:211–215.PubMedGoogle Scholar
  102. 102.
    Cicala RS, Westbrook L, Angel JJ. Side effects and complications of cervical epidural steroid injections. J Pain Symptom Manage 1989;4:64–66.PubMedGoogle Scholar
  103. 103.
    Botwin KP, Castellanos R, Rao S, et al. Complications of fluoroscopically guided interlaminar cervical epidural injections. Arch Phys Med Rehabil 2003;84:627–633.PubMedGoogle Scholar
  104. 104.
    Waldman SD. Complications of cervical epidural nerve blocks with steroids: a prospective study of 790 consecutive blocks. Reg Anesth 1989;14:149–151.PubMedGoogle Scholar
  105. 105.
    Goebert HW Jr, Jallo SJ, Gardner WJ, Wasmuth CE. Painful radiculopathy treated with epidural injections of procaine and hydrocortisone acetate: results in 113 patients. Anesth Analg 1961;40:130–134.PubMedGoogle Scholar
  106. 106.
    Harley C. Extradural corticosteroid infiltration. A follow-up study of 50 cases. Ann Phys Med 1967;9:22–28.PubMedGoogle Scholar
  107. 107.
    Botwin KP, Gruber RD, Bouchlas CG, et al. Complications of fluoroscopically guided caudal epidural injections. Am J Phys Med Rehabil 2001;80:416–424.PubMedGoogle Scholar
  108. 108.
    Ridley MG, Kingsley GH, Gibson T, Grahame R. Outpatient lumbar epidural corticosteroid injection in the management of sciatica. Br J Rheumatol 1988;27:295–299.PubMedGoogle Scholar
  109. 109.
    Wagner AL. CT fluoroscopy-guided epidural injections: technique and results. AJNR Am J Neuroradiol 2004;25:1821–1823.PubMedGoogle Scholar
  110. 110.
    Johnson BA, Schellhas KP, Pollei SR. Epidurography and therapeutic epidural injections: technical considerations and experience with 5334 cases. AJNR Am J Neuroradiol 1999;20:697–705.PubMedGoogle Scholar
  111. 111.
    Forrest JB. The response to epidural steroid injections in chronic dorsal root pain. Can Anaesth Soc J 1980;27:40–46.PubMedGoogle Scholar
  112. 112.
    Wallace G, Solove GJ. Epidural steroid therapy for low back pain. Postgrad Med 1985;78:213–215, 218.PubMedGoogle Scholar
  113. 113.
    Abram SE. Subarachnoid corticosteroid injection following inadequate response to epidural steroids for sciatica. Anesth Analg 1978;57:313–315.PubMedGoogle Scholar
  114. 114.
    Ochani TD, Almirante J, Siddiqui A, Kaplan R. Allergic reaction to spinal cord stimulator. Clin J Pain 2000;16:178–180.PubMedGoogle Scholar
  115. 115.
    Simon DL, Kunz RD, German JD, Zivkovich V. Allergic or Pseudoallergie reaction following epidural steroid deposition and skin testing. Reg Anesth 1989;14:253–255.PubMedGoogle Scholar
  116. 116.
    McAllister RK, McDavid AJ, Meyer TA, Bittenbinder TM. Recurrent persistent hiccups after epidural steroid injection and analgesia with bupivacaine. Anesth Analg 2005;100:1834–1836.PubMedGoogle Scholar
  117. 117.
    Young WF. Transient blindness after lumbar epidural steroid injection: a case report and literature review. Spine 2002;27:E476–E477.PubMedGoogle Scholar
  118. 118.
    Reitman CA, Watters Will. Subdural hematoma after cervical epidural steroid injection. Spine 2002;27:E174–E176.PubMedGoogle Scholar
  119. 119.
    Williams KN, Jackowski A, Evans PJ. Epidural haematoma requiring surgical decompression following repeated cervical epidural steroid injections for chronic pain. Pain 1990;42:197–199.PubMedGoogle Scholar
  120. 120.
    Hodges SD, Castleberg RL, Miller T, Ward R, Thornburg C. Cervical epidural steroid injection with intrinsic spinal cord damage. Two case reports. Spine 1998;23:2137–2142.PubMedGoogle Scholar
  121. 121.
    Candido K, Stevens RA. Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract Res Clin Anaesthesiol 2003;17:407–428.PubMedGoogle Scholar
  122. 122.
    Lauretti GR, Trevelin WR, Frade LC, Lima IC. Spinal alcohol neurolysis for intractable thoracic postherpetic neuralgia after test bupivacaine spinal analgesia. Anesthesiology 2004;101:244–247.PubMedGoogle Scholar
  123. 123.
    Mahli A, Coskun D, Altun NS, Simsek A, Ocal E, Kostekci M. Alcohol neurolysis for persistent pain caused by superior cluneal nerves injury after iliac crest bone graft harvesting in orthopedic surgery: report of four cases and review of the literature. Spine 2002;27:E478–E481.PubMedGoogle Scholar
  124. 124.
    Jang SH, Ahn SH, Park SM, Kim SH, Lee KH, Lee ZI. Alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle to treat ankle spasticity in patients with hemiplegic stroke. Arch Phys Med Rehabil 2004;85:506–508.PubMedGoogle Scholar
  125. 125.
    Atkinson GL, Shupak RC. Acute bronchospasm complicating intercostal nerve block with phenol. Anesth Analg 1989;68:400–401.PubMedGoogle Scholar
  126. 126.
    Mullin V. Brachial plexus block with phenol for painful arm associated with Pancoast’s syndrome. Anesthesiology 1980;53:431–433.PubMedGoogle Scholar
  127. 127.
    Kaplan R, Aurellano Z, Pfisterer W. Phenol brachial plexus block for upper extremity cancer pain. Reg Anesth 1988;13:58.Google Scholar
  128. 128.
    Patt RB, Millard R. A role for peripheral neurolysis in the management of intractable cancer pain. Pain 1990;5(suppl):S358.Google Scholar
  129. 129.
    Kowalewski R, Schurch B, Hodler J, Borgeat A. Persistent paraplegia after an aqueous 7.5% phenol solution to the anterior motor root for intercostal neurolysis: a case report. Arch Phys Med Rehabil 2002;83:283–285.PubMedGoogle Scholar
  130. 130.
    McGarvey ML, Ferrante FM, Patel RS, Maljian JA, Stecker M. Irreversible spinal cord injury as a complication of subarachnoid ethanol neurolysis. Neurology 2000;54:1522–1524.PubMedGoogle Scholar
  131. 131.
    Totoki T, Kato T, Nomoto Y, Kurakazu M, Kanaseki T. Anterior spinal artery syndrome — a complication of cervical intrathecal phenol injection. Pain 1979;6:99–104.PubMedGoogle Scholar
  132. 132.
    Hughes JT. Thrombosis of the posterior spinal arteries. A complication of an intrathecal injection of phenol. Neurology 1970;20:659–664.PubMedGoogle Scholar
  133. 133.
    Slatkin NE, Rhiner M. Phenol saddle blocks for intractable pain at end of life: report of four cases and literature review. Am J Hosp Palliat Care 2003;20:62–66.PubMedGoogle Scholar
  134. 134.
    Korevaar WC. Transcatheter thoracic epidural neurolysis using ethyl alcohol. Anesthesiology 1988;69:989–993.PubMedGoogle Scholar
  135. 135.
    Swerdlow M. Intrathecal and extradural block. In: Relief of Intractable Pain. 2nd ed. Amsterdam: Excerpta Medica; 1978.Google Scholar
  136. 136.
    Robertson DH. Transsacral neurolytic nerve block. An alternative approach to intractable perineal pain. Br J Anaesth 1983;55:873–875.PubMedGoogle Scholar
  137. 137.
    Goffen BS. Transsacral block. Anesth Analg 1982;61:623–624.PubMedGoogle Scholar
  138. 138.
    Wood KM. The use of phenol as a neurolytic agent: a review. Pain 1978;5:205–229.PubMedGoogle Scholar
  139. 139.
    Raj PP. Peripheral neurolysis in the management of pain. In: Waldman SD, Winnie AP, eds. Interventional Pain Management. Philadelphia: WB Saunders; 1996:392.Google Scholar
  140. 140.
    Roviaro GC, Varoli F, Fascianella A, et al. Intrathoracic intercostal nerve block with phenol in open chest surgery. A randomized study with statistical evaluation of respiratory parameters. Chest 1986;90:64–67.PubMedGoogle Scholar
  141. 141.
    DuPen SL. Epidural techniques for cancer pain management: when, why, and how? Curr Rev Pain 1999;3:183–189.PubMedGoogle Scholar
  142. 142.
    Mercadante S. Epidural treatment in advanced cancer patients. Anesth Analg 2004;98: 1503–1504.PubMedGoogle Scholar
  143. 143.
    Rauck RL, Cherry D, Boyer MF, Kosek P, Dunn J, Alo K. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain 2003;4:441–447.PubMedGoogle Scholar
  144. 144.
    Kedlaya D, Reynolds L, Waldman S. Epidural and intrathecal analgesia for cancer pain. Best Pract Res Clin Anaesthesiol 2002;16:651–665.PubMedGoogle Scholar
  145. 145.
    Ferrante FM. Neuraxial infusion in the management of cancer pain. Oncology (Williston Park) 1999;13:30–36.Google Scholar
  146. 146.
    Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;20:4040–4049.PubMedGoogle Scholar
  147. 147.
    Prager J P. Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin. Spine 2002;27:2593–2605.PubMedGoogle Scholar
  148. 148.
    Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain 2004;109:242–249.PubMedGoogle Scholar
  149. 149.
    Cherry DA, Gourlay GK, Eldredge KA. Management of chronic intractable angina —spinal opioids offer an alternative therapy. Pain 2003;102:163–166.PubMedGoogle Scholar
  150. 150.
    Baker L, Lee M, Regnard C, Crack L, Callin S. Evolving spinal analgesia practice in palliative care. Palliat Med 2004;18:507–515.PubMedGoogle Scholar
  151. 151.
    Plassat R, Perrouin VB, Menei P, Menegalli D, Mathe JF, Richard I. Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 2004;42:686–693.PubMedGoogle Scholar
  152. 152.
    Prager JP. Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin. Spine 2002;27:2593–2605.PubMedGoogle Scholar
  153. 153.
    Ripamonti C, Bruneiii C. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2003;21:2801–2802.PubMedGoogle Scholar
  154. 154.
    Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 2000;19:209–215.PubMedGoogle Scholar
  155. 155.
    Du Pen S. Complications of neuraxial infusion in cancer patients. Oncology (Williston Park) 1999;13:45–51.Google Scholar
  156. 156.
    Wallace M, Yaksh TL. Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med 2000;25:117–157.PubMedGoogle Scholar
  157. 157.
    Dickson D. Risks and benefits of long-term intrathecal analgesia. Anaesthesia 2004;59: 633–635.PubMedGoogle Scholar
  158. 158.
    Findler G, Olshwang D, Hadani M. Continuous epidural morphine treatment for intrac-table pain in terminal cancer patients. Pain 1982;14:311–315.PubMedGoogle Scholar
  159. 159.
    Malone BT, Beye R, Walker J. Management of pain in the terminally ill by administration of epidural narcotics. Cancer 1985;55:438–440.PubMedGoogle Scholar
  160. 160.
    Zenz M, Piepenbrock S, Tryba M. Epidural opiates: long-term experiences in cancer pain. Klin Wochenschr 1985;63:225–229.PubMedGoogle Scholar
  161. 161.
    Du Pen SL, Peterson DG, Williams A, Bogosian AJ. Infection during chronic epidural catheterization: diagnosis and treatment. Anesthesiology 1990;73:905–909.PubMedGoogle Scholar
  162. 162.
    DuPen SL, Peterson DG, Bogosian AC, Ramsey DH, Larson C, Omoto M. A new permanent exteriorized epidural catheter for narcotic self-administration to control cancer pain. Cancer 1987;59:986–993.PubMedGoogle Scholar
  163. 163.
    Downing JE, Busch EH, Stedman PM. Epidural morphine delivered by a percutaneous epidural catheter for outpatient treatment of cancer pain. Anesth Analg 1988;67:1159–1161.PubMedGoogle Scholar
  164. 164.
    Boersma FP, Noorduin H, Vanden Bussche G. Epidural sufentanil for cancer pain control in outpatients. Reg Anesth 1989;14:293–297.PubMedGoogle Scholar
  165. 165.
    Driessen JJ, de Mulder PH, Claessen JJ, van Diejen D, Wobbes T. Epidural administration of morphine for control of cancer pain: long-term efficacy and complications. Clin J Pain 1989;5:217–222.PubMedGoogle Scholar
  166. 166.
    Hogan Q, Haddox JD, Abram S, Weissman D, Taylor ML, Janjan N. Epidural opiates and local anesthetics for the management of cancer pain. Pain 1991;46:271–279.PubMedGoogle Scholar
  167. 167.
    Plummer JL, Cherry DA, Cousins MJ, Gourlay GK, Onley MM, Evans KH. Long-term spinal administration of morphine in cancer and non-cancer pain: a retrospective study. Pain 1991;44:215–220.PubMedGoogle Scholar
  168. 168.
    Erdine S, Aldemir T. Long-term results of peridural morphine in 225 patients. Pain 1991;45:155–159.PubMedGoogle Scholar
  169. 169.
    Crul BJ, Delhaas EM. Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients: a review of 140 cases. Reg Anesth 1991;16:209–213.PubMedGoogle Scholar
  170. 170.
    Smitt PS, Tsafka A, Teng-van de Zande F, et al. Outcome and complications of epidural analgesia in patients with chronic cancer pain. Cancer 1998;83:2015–2022.PubMedGoogle Scholar
  171. 171.
    Sillevis SP, Tsafka A, van den BM, et al. Spinal epidural abscess complicating chronic epidural analgesia in 11 cancer patients: clinical findings and magnetic resonance imaging. J Neurol 1999;246:815–820.Google Scholar
  172. 172.
    Schoeffler P, Pichard E, Ramboatiana R, Joyon D, Haberer JP. Bacterial meningitis due to infection of a lumbar drug release system in patients with cancer pain. Pain 1986;25:75–77.PubMedGoogle Scholar
  173. 173.
    Nitescu P, Appelgren L, Hultman E, Linder LE, Sjoberg M, Curelaru I. Long-term, open catheterization of the spinal subarachnoid space for continuous infusion of narcotic and bupivacaine in patients with “refractory” cancer pain. A technique of catheterization and its problems and complications. Clin J Pain 1991;7:143–161.PubMedGoogle Scholar
  174. 174.
    Nitescu P, Sjoberg M, Appelgren L, Curelaru I. Complications of intrathecal opioids and bupivacaine in the treatment of “refractory” cancer pain. Clin J Pain 1995;11:45–62.PubMedGoogle Scholar
  175. 175.
    Gilmer-Hill HS, Boggan JE, Smith KA, Wagner FC Jr. Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature. Surg Neurol 1999;51:12–15.PubMedGoogle Scholar
  176. 176.
    Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999;44:289–300.PubMedGoogle Scholar
  177. 177.
    Krames ES, Chappie I, The 8703 W. Catheter Study Group. Reliability and clinical utility of an implanted intraspinal catheter used in the treatment of spasticity and pain. Neuromodulation 2000;3:7–14.Google Scholar
  178. 178.
    Coffey RJ, Burchiel K. Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery 2002;50:78–86.PubMedGoogle Scholar
  179. 179.
    McMillan MR, Doud T, Nugent W. Catheter-associated masses in patients receiving intrathecal analgesic therapy. Anesth Analg 2003;96:186–190.PubMedGoogle Scholar
  180. 180.
    De Cicco M, Matovic M, Castellani GT, et al. Time-dependent efficacy of bacterial filters and infection risk in long-term epidural catheterization. Anesthesiology 1995;82:765–771.PubMedGoogle Scholar
  181. 181.
    Gaertner J, Sabatowski R, Eisner F, Radbruch L. Encapsulation of an intrathecal catheter. Pain 2003;103:217–220.PubMedGoogle Scholar
  182. 182.
    de Jong PC, Kansen PJ. A comparison of epidural catheters with or without subcutaneous injection ports for treatment of cancer pain. Anesth Analg 1994;78:94–100.PubMedGoogle Scholar
  183. 183.
    Krames ES, Chappie I, The 8703 W. Catheter Study Group. Reliability and clinical utility of an implanted intraspinal catheter used in the treatment of spasticity and pain. Neuromodulation 2000;3:7–14.Google Scholar
  184. 184.
    Staats PS, Yearwood T, Charapata SG, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 2004;291:63–70.PubMedGoogle Scholar
  185. 185.
    Du Pen SL, Kharasch ED, Williams A, et al. Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. Pain 1992;49:293–300.PubMedGoogle Scholar
  186. 186.
    Sjoberg M, Nitescu P, Appelgren L, Curelaru I. Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml. Anesthesiology 1994;80:284–297.PubMedGoogle Scholar
  187. 187.
    Nitescu P, Sjoberg M, Appelgren L, Curelaru I. Complications of intrathecal opioids and bupivacaine in the treatment of “refractory” cancer pain. Clin J Pain 1995;11:45–62.PubMedGoogle Scholar
  188. 188.
    Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458–467.PubMedGoogle Scholar
  189. 189.
    Naumann C, Erdine S, Koulousakis A, Van Buyten JP, Schuchard M. Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management. Neuromodulation 1999;2:92–107.Google Scholar
  190. 190.
    Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215–2222.PubMedGoogle Scholar
  191. 191.
    Du Pen SL, Kharasch ED, Williams A, et al. Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. Pain 1992;49:293–300.PubMedGoogle Scholar
  192. 192.
    Yang CP, Yeh CC, Wong CS, Wu CT. Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain. Anesth Analg 2004;98:557–558.PubMedGoogle Scholar
  193. 193.
    Buchser E, Durrer A, Chedel D, Mustaki JP. Efficacy of intrathecal bupivacaine: how important is the flow rate? Pain Med 2004;5:248–252.PubMedGoogle Scholar
  194. 194.
    Sjoberg M, Nitescu P, Appelgren L, Curelaru I. Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75mg/ml. Anesthesiology 1994;80:284–297.PubMedGoogle Scholar
  195. 195.
    de Jong PC, Kansen PJ. A comparison of epidural catheters with or without subcutaneous injection ports for treatment of cancer pain. Anesth Analg 1994;78:94–100.PubMedGoogle Scholar
  196. 196.
    Taha J, Favre J, Janszen M, Galarza M, Taha A. Correlation between withdrawal symp-toms and medication pump residual volume in patients with implantable SynchroMed pumps. Neurosurgery 2004;55:390–393.PubMedGoogle Scholar
  197. 197.
    de Jong PC, Kansen PJ. A comparison of epidural catheters with or without subcutaneous injection ports for treatment of cancer pain. Anesth Analg 1994;78:94–100.PubMedGoogle Scholar
  198. 198.
    Perren F, Buchser E, Chedel D, Hirt L, Maeder P, Vingerhoets F. Spinal cord lesion after long-term intrathecal Clonidine and bupivacaine treatment for the management of intractable pain. Pain 2004;109:189–194.PubMedGoogle Scholar
  199. 199.
    Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med 2002;3:300–312.PubMedGoogle Scholar
  200. 200.
    Peng P, Massicotte EM. Spinal cord compression from intrathecal catheter-tip inflamma-tory mass: case report and a review of etiology. Reg Anesth Pain Med 2004;29:237–242.PubMedGoogle Scholar
  201. 201.
    Gradert TL, Baze WB, Satterfield WC, Hildebrand KR, Johansen MJ, Hassenbusch SJ. Safety of chronic intrathecal morphine infusion in a sheep model. Anesthesiology 2003; 99:188–198.PubMedGoogle Scholar
  202. 202.
    Yaksh TL, Horais KA, Tozier NA, et al. Chronically infused intrathecal morphine in dogs. Anesthesiology 2003;99:174–187.PubMedGoogle Scholar
  203. 203.
    Johansen MJ, Satterfield WC, Baze WB, Hildebrand KR, Gradert TL, Hassenbusch SJ. Continuous intrathecal infusion of hydromorphone: safety in the sheep model and clinical implications. Pain Med 2004;5:14–25.PubMedGoogle Scholar
  204. 204.
    Yaksh TL, Horais KA, Tozier NA, et al. Chronically infused intrathecal morphine in dogs. Anesthesiology 2003;99:174–187.PubMedGoogle Scholar
  205. 205.
    Nitescu P, Sjoberg M, Appelgren L, Curelaru I. Complications of intrathecal opioids and bupivacaine in the treatment of “refractory” cancer pain. Clin J Pain 1995;11:45–62.PubMedGoogle Scholar
  206. 206.
    Hartrick CT, Pither CE, Pai U, Raj PP, Tomsick TA. Subdural migration of an epidural catheter. Anesth Analg 1985;64:175–178.PubMedGoogle Scholar
  207. 207.
    Barnes RK. Delayed subarachnoid migration of an epidural catheter. Anaesth Intensive Care 1990;18:564–566.PubMedGoogle Scholar
  208. 208.
    Kemler MA, De Vet HC, Barendse GA, Van Den Wildenberg FA, van Kleef M. The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years’ follow-up of the randomized controlled trial. Ann Neurol 2004;55:13–18.PubMedGoogle Scholar
  209. 209.
    North RB, Kidd DH, Farrokhi F, Piantadosi SA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurgery 2005;56:98–106.PubMedGoogle Scholar
  210. 210.
    Turner JA, Loeser JD, Deyo RA, Sanders SB. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications. Pain 2004;108:137–147.PubMedGoogle Scholar
  211. 211.
    North RB, Kidd DH, Farrokhi F, Piantadosi SA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurgery 2005;56:98–106.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Philip W. H. Peng
    • 1
  • Vincent W. S. Chan
    • 1
  1. 1.Department of AnesthesiaUniversity of TorontoTorontoCanada

Personalised recommendations